Skip to content
← Back to this collection

PUBLICATIONS · 23934933

Intensive induction chemotherapy followed by myeloablative chemotherapy with autologous hematopoietic progenitor cell rescue for young children newly-diagnosed with central nervous system atypical teratoid/rhabdoid tumors: the Head Start III experience.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Pediatr Blood Cancer
Publication date
2014 Jan
First author
Zaky W

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships

    Authors and identifiers

    1. name
      Zaky W
      type
      Author
    2. name
      Dhall G
      type
      Author
    3. name
      Ji L
      type
      Author
    4. name
      Haley K
      type
      Author
    5. name
      Allen J
      type
      Author
    6. name
      Atlas M
      type
      Author
    7. name
      Bertolone S
      type
      Author
    8. name
      Cornelius A
      type
      Author
    9. name
      Gardner S
      type
      Author
    10. name
      Patel R
      type
      Author
    11. name
      Pradhan K
      type
      Author
    12. name
      Shen V
      type
      Author
    Complete bibliographic record and source provenance
    authors
    1. name
      Zaky W
      type
      Author
    2. name
      Dhall G
      type
      Author
    3. name
      Ji L
      type
      Author
    4. name
      Haley K
      type
      Author
    5. name
      Allen J
      type
      Author
    6. name
      Atlas M
      type
      Author
    7. name
      Bertolone S
      type
      Author
    8. name
      Cornelius A
      type
      Author
    9. name
      Gardner S
      type
      Author
    10. name
      Patel R
      type
      Author
    11. name
      Pradhan K
      type
      Author
    12. name
      Shen V
      type
      Author
    bibliography ids
    1. nci-bib-8c0182d1b7f47bd7c9ea0758
    book metadata
    content sha256
    97b203e6a30e2f287d9448f6210c172992759d14deeba751309e0b02aa34d0e1
    document type
    citation
    dois
    1. 10.1002/pbc.24648
    electronic publication date
    display
    2013 Aug 11
    precision
    day
    year
    2013
    evidence scope
    bibliographic_metadata_only
    id
    pubmed:23934933
    immutable id
    pubmed:23934933@97b203e6a30e2f287d9448f6210c172992759d14deeba751309e0b02aa34d0e1
    journal
    abbreviation
    Pediatr Blood Cancer
    issn electronic
    1545-5017
    issn print
    1545-5009
    issue
    1
    name
    Pediatric blood & cancer
    nlm unique id
    101186624
    pages
    95-101
    volume
    61
    languages
    1. eng
    notices
    absence is not clearance
    true
    has correction metadata
    false
    has expression of concern metadata
    false
    has retraction in link
    false
    pubmed marks article retracted
    false
    pubmed marks retraction notice
    false
    relationships
      outcomes validated
      false
      pmid
      23934933
      provenance
      batch id
      0a08f044391426feb8ef
      provider
      NCBI PubMed ESummary
      record sha256
      6a82895bcc5fcbd0381a5f830a9ffc9b0b9f4b8d8e5bf37e045589d7daa2dbcf
      response sha256
      d94e6242343e5962374663e5e5f0191e7b595329228d2e360db95a280e588409
      retrieved at
      2026-09-09T23:46:57.614689+00:00
      publication date
      display
      2014 Jan
      precision
      month
      year
      2014
      publication types
      1. Clinical Trial
      2. Journal Article
      3. Multicenter Study
      4. Research Support, Non-U.S. Gov't
      record status
      PubMed - indexed for MEDLINE
      schema version
      1.0
      source url
      https://pubmed.ncbi.nlm.nih.gov/23934933/
      title
      Intensive induction chemotherapy followed by myeloablative chemotherapy with autologous hematopoietic progenitor cell rescue for young children newly-diagnosed with central nervous system atypical teratoid/rhabdoid tumors: the Head Start III experience.

      Preserved source evidence · Not medical advice